Ingancin Maganin CD7 CAR-T ga Cututtukan B-Cell: Nasara a Maganin Ciwon Daji

2024-09-06

Binciken da aka yi kwanan nan ya nuna inganci da amincin maganin ƙwayoyin CD7 CAR-T wajen magance cutar sankarar jini mai saurin kamuwa da cutar B-cell lymphoblastic leukemia (B-ALL) da kuma cutar sankarar lymphoblastic T-cell (T-LBL). Binciken da BIOOCUS ta gudanar tare da haɗin gwiwar Asibitin Lu Daopei, ya nuna sakamako mai kyau ga marasa lafiya, yana ba da madadin maganin chemotherapy na gargajiya.

A cikin wani ci gaba mai ban sha'awa ga Maganin Ciwon daji, BIOOCUS, tare da haɗin gwiwar Asibitin Lu Daopei, sun bayyana wani sabon bincike kan amfani da maganin T-cell na CD7 chimeric antigen receptor (CAR). Wannan sabuwar hanyar, wacce ke nufin sake dawowa ko kuma rashin ƙarfin B-cell acute lymphoblastic leukemia (B-ALL) da T-cell lymphoblastic lymphoma (T-LBL), tana nuna inganci da aminci mai yawa, wanda ke inganta sakamakon marasa lafiya sosai.

Binciken, wanda aka buga a cikin wata mujalla mai daraja, ya ƙunshi kwatanta marasa lafiya da suka karɓi maganin CD7 CAR-T tare da haɗa su da dashen ƙwayoyin halitta na allogeneic hematopoietic (allo-HSCT) idan aka kwatanta da waɗanda aka yi wa magani da maganin chemotherapy kafin a yi musu dashen. Binciken ya nuna cewa marasa lafiyar da suka sami cikakkiyar gafara (CR) tare da maganin CD7 CAR-T suna da sakamako na rayuwa na dogon lokaci kamar waɗanda aka yi wa magani da maganin chemotherapy na gargajiya. Abu mai mahimmanci, binciken bai sami wani ƙaruwa mai yawa a cikin rikice-rikicen bayan dashen ba, kamar cututtukan dashen-dashen-gida (GVHD), kamuwa da cuta, ko wasu abubuwan da suka faru marasa kyau.

9.6.png

Muhimman abubuwan da suka faru a binciken sun hada da:

Cikakken Adadin Rangwame: Maganin CD7 CAR-T ya nuna cikakken sassauci, inda sama da kashi 97% na marasa lafiya suka mayar da martani mai kyau ga maganin.
Bayanin Tsaro: Duk da sabuwar hanyar amfani da maganin CAR-T, an jure wa maganin sosai, ba tare da wata illa ba kuma babu wani ƙaruwa mai yawa a cikin GVHD mai inganci ko wasu matsaloli masu tsanani.
Nasarar Bayan Dashen: Marasa lafiya da aka yi musu allurar allo-HSCT bayan sun sami CR tare da maganin CD7 CAR-T sun sami kyakkyawan rayuwa gaba ɗaya (OS) da rayuwa ba tare da cutar sankarar bargo ba (LFS), wanda aka yi daidai da jiyya ta gargajiya da aka yi bisa ga chemotherapy.

Wannan bincike yana nuna wani muhimmin ci gaba a fannin tattalin arziki Ciwon daji Immunotherapy, yana ba da bege ga marasa lafiya da ke fama da cutar sankarar bargo da lymphoma da suka sake dawowa ko kuma suka yi tsauri. BIOOCUS ya ci gaba da jajircewa wajen haɓaka iyakokin maganin CAR-T, yana samar da mafita mai inganci ga marasa lafiya da suka gaji da zaɓuɓɓukan magani na gargajiya. Yayin da duniya ke rungumar waɗannan hanyoyin magani na zamani, BIOOCUS tana kan gaba wajen haɓaka magunguna waɗanda ke kawo canji na gaske ga sakamakon marasa lafiya.